AMBQ vs MSFT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AMBQ exhibits severe financial distress signals, with a Piotroski F-Score of 1/9 indicating extreme operational weakness and no Altman Z-Score available, raising unquantified bankruptcy risk. Despite a strong gross margin of 44.26%, the company reports deep losses across all profitability metrics, including a -50.28% net profit margin and negative ROE/ROA. Insider selling of $0.55M in the last 6 months, coupled with a 34.2% decline over the past year, underscores deteriorating sentiment. While earnings surprises have been positive in recent quarters, they stem from shrinking losses rather than real profitability, and revenue growth is negligible at just 2% YoY. The stock trades at a premium valuation (Price/Sales: 7.33) despite negative earnings and no intrinsic value support.
Microsoft exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust financial stability. While the stock is currently experiencing a severe technical downtrend (0/100) and significant 6-month price depreciation (-28.6%), the current price of $374.33 sits well below the growth-based intrinsic value of $471.41 and the analyst target of $587.31. Exceptional earnings growth (59.8% YoY) and high operating margins (47.09%) suggest that the current price correction presents a value opportunity despite bearish insider sentiment.
Compare Another Pair
Related Comparisons
AMBQ vs MSFT: Head-to-Head Comparison
This page compares Ambiq Micro, Inc. (AMBQ) and Microsoft Corporation (MSFT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.